Sun Life Financial (SLF) Q3 2024 earnings summary

Executive summary

• Underlying net income rose 9% year-over-year to over CAD 1 billion, with reported net income up 55% to CAD 1.348 billion, reflecting strong diversified business performance and favorable market impacts.

• Underlying EPS increased 11% to CAD 1.76; reported EPS climbed 57% to CAD 2.33 compared to Q3'23.

• Assets under management reached a record $1.5 trillion, up 13% year-over-year, despite net outflows in wealth and asset management.

• Group Health & Protection sales grew 19% and Individual Protection sales grew 9% year-over-year.

• Dividend per common share increased by 3 cents to $0.84.

Financial highlights

• Underlying net income rose 9% year-over-year to over CAD 1 billion; underlying EPS up 11% to CAD 1.76.

• Underlying ROE was 17.9%, and reported ROE reached 23.8% for Q3'24.

• Reported net income was CAD 1.348 billion, CAD 332 million above underlying, driven by acquisition-related liability updates and favorable market impacts.

• Book value per share increased 6% year-over-year to $39.88.

• New business CSM was $383 million, up 4% year-over-year; total CSM at $12.8 billion, up 12%.

Outlook and guidance

• 80% of targeted CAD 200 million in restructuring savings to be realized by end of 2025, supporting higher-end EPS growth.

• Dental business in the U.S. expected to achieve $100 million in earnings in 2025, with 61% of necessary pricing actions already implemented.

• Focus remains on accelerating Asia momentum, deepening client health impact, and digital transformation.

• Organic capital generation remains strong, with medium-term guidance of 25%-35% of underlying net income.

• Forward-looking statements caution on market, insurance, credit, operational, and regulatory risks.